IL2 and tuberculosis: While adjunctive ZOL/IL-2 regimen clearly could result in milder MDR-TB pathology than TB drugs alone or saline controls, there was no significant difference in TB pathology between ZOL/IL-2-treated and IL-2-treated macaques.